2-Deoxy-2-fluoro-D-glucose-13C6 is a carbon-13 labeled derivative of 2-deoxy-2-fluoro-D-glucose (FDG), a glucose analog used in positron emission tomography (PET) imaging. The carbon-13 labeling at six positions enhances its application in mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy by providing improved sensitivity and resolution. This labeled compound is essential for detailed studies of glucose metabolism and cellular uptake in research. It aids in optimizing PET imaging techniques, understanding metabolic pathways, and studying the pharmacokinetics of glucose analogs in various biological systems.
| Catalog Number | R041090 |
| CAS Number | NA |
| Synonyms | 2-Deoxy-2-fluoro-D-glucopyranose-13C6; 2-Deoxy-2-fluoroglucose-13C6; FDG-13C6; |
| Molecular Formula | ¹³C₆H₁₁FO₅ |
| Purity | 95% |
| Storage | Desiccate at RT |
| IUPAC Name | 3-fluoro-6-(hydroxy(113C)methyl)(2,3,4,5,6-13C5)oxane-2,4,5-triol |
| InChI | InChI=1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/i1+1,2+1,3+1,4+1,5+1,6+1 |
| InChIKey | ZCXUVYAZINUVJD-IDEBNGHGSA-N |
| SMILES | [13CH2]([13CH]1[13CH]([13CH]([13CH]([13CH](O1)O)F)O)O)O |
